Evidence map›Paper›PMID 38592597›Full record

ArticleNeuromolecular medicine2024

The Relationship Between CYP46A1 Polymorphism and Suicide Risk: A Preliminary Investigation.

María Fernanda Serna-Rodríguez, Oscar Cienfuegos-Jiménez, Ricardo Martín Cerda-Flores, Iván Alberto Marino-Martínez, Mario Alberto Hernández-Ordoñez, José Alfonso Ontiveros-Sánchez de la Barquera, Antonio Alí Pérez-Maya

Abstract read
PubMed Publisher
In one paragraph

Article in Neuromolecular medicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed, 1 pooled it
0.3field-weighted citation impact, top 49% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 synthesis or guideline pooled it, 1 citations in OpenAlex.

  1. Pooled it
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

María Fernanda Serna-RodríguezDepartamento de Bioquímica y Medicina Molecular, Facultad de Medicina, Universidad Autónoma de Nuevo León, CP 64460, Monterrey, N.L., México.
Oscar Cienfuegos-JiménezCentro de Investigación y Desarrollo, en Ciencias de la Salud de la Universidad Autónoma de Nuevo León, CP 64460, Monterrey, N.L., México.
Ricardo Martín Cerda-FloresFacultad de Enfermería, Universidad Autónoma de Nuevo León, Av. Dr. José Eleuterio González 1500, Mitras Centro, CP 64460, Monterrey, N.L., Mexico.
Iván Alberto Marino-MartínezCentro de Investigación y Desarrollo, en Ciencias de la Salud de la Universidad Autónoma de Nuevo León, CP 64460, Monterrey, N.L., México.
Mario Alberto Hernández-OrdoñezDepartamento de Medicina Forense, Hospital Universitario "Dr. José Eleuterio González", Universidad Autónoma de Nuevo León, Av. Francisco I. Madero y Av. Gonzalitos s/n, Mitras Centro, CP 64460, Monterrey, N.L., Mexico.
José Alfonso Ontiveros-Sánchez de la BarqueraDepartamento de Psiquiatría, Hospital Universitario "Dr. José Eleuterio González", Universidad Autónoma de Nuevo León, Av. Francisco I. Madero y Av. Gonzalitos s/n, Mitras Centro, CP 64460, Monterrey, N.L., Mexico.
Antonio Alí Pérez-MayaDepartamento de Bioquímica y Medicina Molecular, Facultad de Medicina, Universidad Autónoma de Nuevo León, CP 64460, Monterrey, N.L., México. bioquimicomty@gmail.com.
Universidad Autónoma de Nuevo León · MXCentro de Investigación y Desarrollo · ESHospital Universitario Dr José Eleuterio Gonzalez · MX

Funding

Consejo Nacional de Ciencia y Tecnología 5012
6 · The paper itself

Abstract

Suicide is a global public health issue, with a particularly high incidence in individuals suffering from Major Depressive Disorder (MDD). The role of cholesterol in suicide risk remains controversial, prompting investigations into genetic markers that may be implicated. This study examines the association between CYP46A1 polymorphisms, specifically SNPs rs754203 and rs4900442, and suicide risk in a Mexican MDD patient cohort. Our study involved 188 unrelated suicide death victims, 126 MDD patients, and 144 non-suicidal controls. Genotypic and allelic frequencies were assessed using the Real Time-polymerase chain reaction method, and associations with suicide risk were evaluated using chi-square tests. The study revealed significant differences in allelic and genotypic frequencies in rs754203 SNP between suicide death and controls. The CYP46A1 rs754203 genotype G/G was significantly linked with suicide, and the G allele was associated with a higher risk of suicide (OR = 1.370, 95% CI = 1.002-1.873). However, we did not observe any significant differences in genotype distribution or allele frequencies of CYP46A1 rs4900442. Our study suggests that carriers of the CYP46A1 rs754203 G allele (A/G + G/G) may play a role in suicidal behavior, especially in males. Our findings support that the CYP46A1 gene may be involved in susceptibility to suicide, which has not been investigated previously. These results underscore the importance of further research in different populations to elucidate the genetic underpinnings of the role of CYP46A1 in suicide risk and to develop targeted interventions for at-risk populations.

Indexed as

Major Depressive DisorderSuicideCholesterol 24-HydroxylaseGene FrequencyHumansMalePolymorphism, Single NucleotideCholesterol 24-HydroxylaseCYP46A1DepressionPolymorphismRisk factorSuicide

Identifiers

PMID38592597
OpenAlexW4394619029

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.